In ovarian cancer, ascitic HE4 and CA125 have been proposed as useful adjuncts when cytology is inconclusive, with multiple studies reporting sensitivities above 80–90% [6,22,32,36,45]. This evidence concerns the gene WFDC2 and ovarian cancer.